{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Impact of Transit-Time Flow Measurement on Postoperative Outcomes in Coronary Artery Bypass Grafting: A Retrospective Analysis"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "A single-centre retrospective analysis was conducted on 910 patients undergoing isolated total arterial coronary artery bypass grafting with internal thoracic arteries (ITAs) at our institution between January 2017 and February 2020."
      },
      "Participants": {
        "score": 2,
        "evidence": "910 patients undergoing isolated total arterial coronary artery bypass grafting with internal thoracic arteries (ITAs) at our institution between January 2017 and February 2020."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were divided based on the use of TTFM: 430 patients in the TTFM group and 480 in the no TTFM group."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the impact of transit-time flow measurement (TTFM) on early postoperative outcomes in total arterial coronary revascularization."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was the occurrence of in-hospital major cardiac adverse events (MACE)."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Participants were divided based on the use of TTFM: 430 patients in the TTFM group and 480 in the no TTFM group."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "MACE were significantly lower in the TTFM group (14, 3.3%) than in the no TTFM group (33, 6.9%, P = 0.014). TTFM was protective against MACE occurrence (odds ratio 0.46, 95% CI 0.23\u20130.85, P = 0.016)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Six (1.4%) patients in the TTFM group underwent intraoperative graft revision due to unsatisfactory flow values, compared to none in the no TTFM group (P = 0.011)."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 11,
    "max_score": 25
  },
  "model": "gpt-4o"
}